These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 36721095)

  • 1. Rapid emergence from dexmedetomidine sedation in Sprague Dawley rats by repurposing an α
    Xie Z; Fox AP
    BMC Anesthesiol; 2023 Feb; 23(1):39. PubMed ID: 36721095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of the sedative and sympatholytic effects of dexmedetomidine with a specific alpha2-adrenoceptor antagonist atipamezole: a pharmacodynamic and kinetic study in healthy volunteers.
    Scheinin H; Aantaa R; Anttila M; Hakola P; Helminen A; Karhuvaara S
    Anesthesiology; 1998 Sep; 89(3):574-84. PubMed ID: 9743392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imidazoline 1 receptor activation preserves respiratory drive in spontaneously breathing newborn rats during dexmedetomidine administration.
    Sato N; Saiki C; Tamiya J; Imai T; Sunada K
    Paediatr Anaesth; 2017 May; 27(5):506-515. PubMed ID: 28177562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of dexmedetomidine and midazolam sedation and antagonism of dexmedetomidine with atipamezole.
    Aho M; Erkola O; Kallio A; Scheinin H; Korttila K
    J Clin Anesth; 1993; 5(3):194-203. PubMed ID: 8100428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of adenosine A1 receptor in nucleus tractus solitarius attenuates baroreflex sensitivity response to dexmedetomidine in rats.
    Tian L; Tang G; Liu Q; Yin Y; Li Y; Zhong Y
    Brain Res; 2020 Sep; 1743():146949. PubMed ID: 32522627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylphenidate Reversal of Dexmedetomidine-Induced Versus Ketamine-Induced Sedation in Rats.
    Vincent KF; Park GH; Stapley BM; Dillon EJ; Solt K
    Anesth Analg; 2024 Aug; ():. PubMed ID: 39110627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The alpha2-adrenoceptor agonist dexmedetomidine converges on an endogenous sleep-promoting pathway to exert its sedative effects.
    Nelson LE; Lu J; Guo T; Saper CB; Franks NP; Maze M
    Anesthesiology; 2003 Feb; 98(2):428-36. PubMed ID: 12552203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sedative but not analgesic alpha2 agonist tolerance is blocked by NMDA receptor and nitric oxide synthase inhibitors.
    Davies MF; Reid K; Guo TZ; Agashe GS; Amin YK; Maze M
    Anesthesiology; 2001 Jul; 95(1):184-91. PubMed ID: 11465557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexmedetomidine injection into the locus ceruleus produces antinociception.
    Guo TZ; Jiang JY; Buttermann AE; Maze M
    Anesthesiology; 1996 Apr; 84(4):873-81. PubMed ID: 8638842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of α2-adorenoceptor agonist dexmedetomidine on respiratory rhythm generation of newborn rats.
    Tsuzawa K; Minoura Y; Takeda S; Inagaki K; Onimaru H
    Neurosci Lett; 2015 Jun; 597():117-20. PubMed ID: 25916879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The alpha 2-adrenoceptor antagonist atipamezole potentiates anti-Parkinsonian effects and can reduce the adverse cardiovascular effects of dopaminergic drugs in rats.
    Haapalinna A; Leino T; Heinonen E
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Nov; 368(5):342-51. PubMed ID: 14566451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuronal ensembles sufficient for recovery sleep and the sedative actions of α2 adrenergic agonists.
    Zhang Z; Ferretti V; Güntan İ; Moro A; Steinberg EA; Ye Z; Zecharia AY; Yu X; Vyssotski AL; Brickley SG; Yustos R; Pillidge ZE; Harding EC; Wisden W; Franks NP
    Nat Neurosci; 2015 Apr; 18(4):553-561. PubMed ID: 25706476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of dexmedetomidine on cardiorespiratory regulation in spontaneously breathing adult rats.
    Kitajima Y; Hashizume NS; Saiki C; Ide R; Imai T
    PLoS One; 2022; 17(1):e0262263. PubMed ID: 35030204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid reversal of alpha 2-adrenoceptor agonist effects by atipamezole in human volunteers.
    Karhuvaara S; Kallio A; Salonen M; Tuominen J; Scheinin M
    Br J Clin Pharmacol; 1991 Feb; 31(2):160-5. PubMed ID: 1675577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The analgesic potency of dexmedetomidine is enhanced after nerve injury: a possible role for peripheral alpha2-adrenoceptors.
    Poree LR; Guo TZ; Kingery WS; Maze M
    Anesth Analg; 1998 Oct; 87(4):941-8. PubMed ID: 9768799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of I1-imidazoline receptors on the sedation effect of dexmedetomidine in mice.
    Han X; Yang ZF; Zhao TY; Lu GY; Wang ZY; Wu N; Li J; Li F
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Aug; 397(8):5927-5937. PubMed ID: 38363351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Actions of alpha2 adrenoceptor ligands at alpha2A and 5-HT1A receptors: the antagonist, atipamezole, and the agonist, dexmedetomidine, are highly selective for alpha2A adrenoceptors.
    Newman-Tancredi A; Nicolas JP; Audinot V; Gavaudan S; Verrièle L; Touzard M; Chaput C; Richard N; Millan MJ
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Aug; 358(2):197-206. PubMed ID: 9750005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. α2-adrenoreceptor modulated FAK pathway induced by dexmedetomidine attenuates pulmonary microvascular hyper-permeability following kidney injury.
    Chen Q; Yi B; Ma J; Ning J; Wu L; Ma D; Lu K; Gu J
    Oncotarget; 2016 Aug; 7(35):55990-56001. PubMed ID: 27463003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. G
    Liu M; Yang Y; Tan B; Li Y; Zhou P; Su R
    Eur J Pharmacol; 2018 Jul; 831():28-37. PubMed ID: 29738700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selectivity of atipamezole, yohimbine and tolazoline for alpha-2 adrenergic receptor subtypes: implications for clinical reversal of alpha-2 adrenergic receptor mediated sedation in sheep.
    Schwartz DD; Clark TP
    J Vet Pharmacol Ther; 1998 Oct; 21(5):342-7. PubMed ID: 9811433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.